Michelle Melisko
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+ (NCT02593708) | Michelle Melisko | 2015-11-03 |
Track Michelle Melisko automatically
Every clearance here is in the API, with alerts when new ones post.